Laura Smith’s default image

By: Laura Smith

In hopes of cutting administrative costs and streamlining the amount of time it takes to get new drugs to consumers, eight global pharmaceutical manufacturers have formed a coalition, SAFE-BioPharma, to support the widespread adoption of the new global digital identity standard, Secure Access for Everyone (SAFE).As the biopharmaceutical industry has become more automated, it’s also become more collaborative.

Tamar June’s picture

By: Tamar June

If you are thinking of CFR 21 Part 11 compliance in terms of what the FDA may or may not require, you are missing a huge opportunity to make your business more efficient, nimble and ultimately profitable by improving the quality of your operation and its products. That’s the consensus of dozens of your competitors at FDA-regulated firms, industry consultants and even FDA agents.“Any electronic record system that can’t comply today should not be in service,” states John McKenney, SEC Associates’ president and CEO.

Tamar June’s picture

By: Tamar June

If you are thinking of CFR 21 Part 11 compliance in terms of what the FDA may or may not require, you are missing a huge opportunity to make your business more efficient, nimble and ultimately profitable by improving the quality of your operation and its products. That’s the consensus of dozens of your competitors at FDA-regulated firms, industry consultants and even FDA agents.“Any electronic record system that can’t comply today should not be in service,” states John McKenney, SEC Associates’ president and CEO.

BSI’s picture

By: BSI

Nancy Fullbright’s default image

By: Nancy Fullbright

Alan Kent, president and CEO of Meadows Regional Medical Center in Vidalia, Ga., was a champion for implementing lean principles in the hospital’s emergency department.

Photo by Gary Meek

Syndicate content